WHO ICTRP trial
Investigation of WCFS1 on the gut microbiota of autistic spectrum disorder (ASD)…
ISRCTN04516575 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN04516575 |
|---|---|
| Public title | Investigation of WCFS1 on the gut microbiota of autistic spectrum disorder (ASD) children |
| Scientific title | Investigation of the effects of Lactobacillus plantarum WCFS1 supplementation on the gut microbiota and gut symptoms of children with autistic spectrum disorder (ASD) |
| Primary sponsor | University of Reading (UK) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | United Kingdom |
| Conditions | Autistic spectrum disorder Mental and Behavioural Disorders Childhood autism |
| Interventions | A randomised placebo-controlled, double blind parallel feeding study testing a probiotic (Lactobacillus plantarum WCFS1) and a placebo. A single dose (4.5x1010 CFU/g) will be consumed daily for period of 6 weeks. |
| Registration date | Dec 28, 2011 |
| Target size | 70 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: